Mumbai-based healthcare startup Vytalyou has raised ₹8-10 crore in growth funding at a reported valuation of around ₹33 crore. The preventive healthcare and longevity platform plans to strengthen its Mumbai presence and expand into other major Indian cities from 2027.
Vytalyou Funding Comes as Preventive Healthcare Gains Ground
The Vytalyou funding round was secured in August 2026 from Chetan Jain of Pharma Dose and Ratan Jain of Venus Industries, according to Business Standard. The Mumbai-based startup plans to use the capital to expand its network, with new centres being developed in Juhu and Worli.
Vytalyou currently operates a centre in Powai and is building a three-location network within Mumbai. The company was incorporated in September 2025 by molecular oncologist Dr Chirantan Bose and radiologist Dr Preetesh Bhandari.
The latest funding comes less than a year after the company was incorporated, placing it among the newer Indian healthcare startups seeking to combine diagnostics, preventive care and longevity-focused services.
Its expansion strategy is based on building physical healthcare centres rather than operating only as a digital health platform.
Mumbai Healthcare Network to Expand Across Three Locations
Vytalyou’s immediate expansion plans are focused on Mumbai.
The company currently has a centre in Powai and is setting up additional locations in Juhu and Worli. This will create a three-centre network within the city, according to the funding report.
The company’s own website identifies its Powai facility as a preventive longevity centre offering diagnostics, IV therapy and other health and wellness services. It also provides home-based sample collection and some home wellness services across Mumbai.
The company has indicated that it intends to enter other major Indian cities in 2027. Details about the specific cities and the timing of individual centre launches have not been disclosed in the available funding report.
This approach allows Vytalyou to establish a stronger presence in its home market before attempting a broader national expansion.
What Vytalyou Offers Through Preventive Healthcare
Vytalyou’s model combines diagnostic testing with preventive healthcare and longevity-focused services.
Its website lists blood and pathology testing, radiology, cardiac evaluation, body composition analysis and genomic testing among its diagnostic offerings. The company also provides physician-supervised IV therapy and other wellness programmes.
Its stated approach is to begin with an assessment of an individual’s health profile and then use diagnostic information to develop a personalised health plan. The company describes its process as combining diagnostics, medical consultation, lifestyle assessment and longevity analysis.
The business is therefore positioned differently from a conventional diagnostic laboratory. Instead of focusing only on individual tests, Vytalyou is attempting to bring diagnostics, preventive assessment and wellness interventions into a single healthcare model.
The company calls this approach a longevity-focused healthcare ecosystem.
Predictive Longevity Evaluation Forms a Core Offering
One of Vytalyou’s central offerings is its Predictive Longevity Evaluation.
According to Business Standard, the evaluation combines blood investigations, ultrasound imaging, body-composition analysis and cardiovascular assessment. The company’s website also describes a broader diagnostic process involving pathology, radiology, genomics and body composition testing.
The idea behind preventive healthcare is to identify potential health risks earlier and encourage individuals to monitor measurable health indicators over time.
However, preventive screening does not mean that every test or intervention is appropriate for every person. Medical screening decisions generally depend on factors such as age, family history, symptoms, existing conditions and clinical guidance.
Vytalyou’s own terms state that information on its website is intended for educational and informational purposes and should not substitute for professional medical advice, diagnosis or treatment.
Vytalyou Founders Bring Specialist Medical Backgrounds
Vytalyou was founded by Dr Chirantan Bose and Dr Preetesh Bhandari.
Business Standard describes Bose as a molecular oncologist and Bhandari as a radiologist. The company’s website similarly identifies the two founders as specialist doctors with backgrounds in molecular oncology, radiology and preventive medicine.
The founders’ medical backgrounds are central to the company’s positioning. Vytalyou describes its model as doctor-supervised and focused on combining medical diagnostics with preventive and longevity services.
This is also reflected in the company’s operating model. Its website says diagnostic evaluations are reviewed by specialist doctors and that health assessments can include pathology, imaging, cardiac evaluation, body composition and genetic testing.
The combination of clinical expertise and consumer-oriented wellness services is becoming more visible across India’s private healthcare market.
Growth Funding Supports Expansion Into New Cities
The ₹8-10 crore funding gives Vytalyou capital to expand its physical network and prepare for entry into other major Indian markets.
Business Standard reported that the company plans to expand in Mumbai and enter other major Indian cities in 2027. The funding was raised at a reported valuation of around ₹33 crore.
The company has not publicly detailed the complete allocation of the funding across real estate, technology, staffing, diagnostics infrastructure and marketing.
For a healthcare business operating physical centres, expansion can involve substantial upfront costs. Locations need medical infrastructure, diagnostic equipment, qualified staff, operational systems and regulatory compliance.
Unlike a software startup that can add customers without opening new physical facilities, a clinic-based healthcare company needs to build capacity as it expands.
That makes capital planning particularly important as Vytalyou moves from one Mumbai location toward a multi-city model.
Why Tier-2 Cities Could Become Relevant
Vytalyou’s current expansion strategy is focused on major Indian cities, but preventive healthcare could eventually create opportunities in Tier-2 markets as well.
Healthcare demand in smaller cities has been expanding alongside improvements in diagnostic infrastructure, specialist availability and consumer awareness. Many patients still travel to larger cities for specialised healthcare services, creating an opportunity for providers that can establish reliable local networks.
For Vytalyou, expansion into smaller cities would require a different operating model from its premium urban centres. The company would need to consider pricing, specialist availability, diagnostic infrastructure and local demand.
The startup has not announced a Tier-2 expansion plan, so such a move should not be treated as an immediate strategy. However, its broader 2027 expansion plans could provide a foundation for examining markets beyond Mumbai and other major metros.
Longevity Healthcare Is a Growing Startup Category
Vytalyou’s funding also reflects the emergence of longevity and preventive healthcare as a distinct startup category.
Traditional healthcare businesses often focus on diagnosing and treating illness after symptoms appear. Preventive healthcare places greater emphasis on screening, monitoring risk factors and making health interventions earlier.
Vytalyou is combining this preventive approach with services such as IV therapy, hyperbaric oxygen therapy, cryotherapy and photobiomodulation. Some of these services are marketed by the company as wellness or longevity interventions, while the scientific evidence and appropriate clinical use can vary by treatment and indication.
That distinction is important because the term longevity covers a wide range of services, from established preventive screening to emerging wellness interventions.
For healthcare startups operating in this space, maintaining appropriate medical supervision and clearly distinguishing established healthcare practices from emerging therapies will remain important as they scale.
The Next Stage Will Test Vytalyou’s Expansion Model
Vytalyou’s immediate priority is to turn its new funding into a larger healthcare network.
The company plans to establish its Juhu and Worli centres, strengthening its presence beyond Powai. It then plans to enter other major Indian cities in 2027.
The expansion will test whether Vytalyou’s integrated model can be replicated across locations while maintaining medical oversight and consistent service quality.
The company’s ability to attract patients, retain customers and manage the costs of physical healthcare infrastructure will also determine how quickly it can scale.
The ₹8-10 crore funding provides the company with additional capital for this next stage. But the longer-term outcome will depend on execution, clinical governance, customer demand and the economics of operating multiple healthcare centres.
For India’s startup ecosystem, the development is another example of investors putting capital into healthcare models that combine technology, diagnostics and preventive services.
Key Takeaways
- Vytalyou has raised ₹8-10 crore in growth funding at a reported valuation of around ₹33 crore.
- The Mumbai-based startup currently operates in Powai and is setting up centres in Juhu and Worli.
- Vytalyou combines diagnostics, preventive healthcare and longevity-focused services under a doctor-supervised model.
- The company plans to enter other major Indian cities in 2027, although specific locations have not yet been announced.
FAQs
What is Vytalyou?
Vytalyou is a Mumbai-based preventive healthcare and longevity startup founded by Dr Chirantan Bose and Dr Preetesh Bhandari. It combines diagnostic services, medical assessments and longevity-focused wellness programmes.
How much funding has Vytalyou raised?
Vytalyou has raised ₹8-10 crore in growth funding. The investment was secured in August 2026 from Chetan Jain of Pharma Dose and Ratan Jain of Venus Industries, according to Business Standard.
Where does Vytalyou currently operate?
Vytalyou currently operates a centre in Powai, Mumbai. It is also setting up centres in Juhu and Worli, which would give the company three Mumbai locations.
What are Vytalyou’s plans for expansion?
The company plans to strengthen its Mumbai network and enter other major Indian cities in 2027. Specific cities outside Mumbai have not been identified in the latest funding announcement.
(Internal keyword suggestions: Vytalyou funding, Vytalyou raises ₹8-10 crore, Vytalyou healthcare startup, Vytalyou Mumbai, preventive healthcare startups India, longevity healthcare India, healthcare funding India 2026, preventive healthcare Mumbai, healthtech startups India, longevity startups India, Vytalyou expansion)
Leave a comment